海康威視(002415.SZ)再創歷史新高 月內累漲近40%
格隆匯1月22日丨海康威視(002415.SZ)盤中拉昇一度漲7.41%至67.88元,再創歷史新高,市值超6300億元。該股自月初開始啟動一波明顯上漲行情,月內已累漲近40%。公司1月初宣佈擬分拆所屬子公司杭州螢石網絡有限公司至科創板上市。公司稱,分拆完成後,海康威視仍將維持對螢石網絡的控股權。通過此次分拆,螢石網絡將作為公司下屬智能家居及雲平台服務業務的上市平台獨立上市,通過科創板上市加大對智能家居綜合解決方案及雲平台服務業務核心技術的進一步投入,實現智能家居業務的做大做強,持續為個人、家庭及類家居場景下的用户提供智能化產品和優質服務。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.